Nina Gliem1, Christoph Ammer-Herrmenau1, Volker Ellenrieder1, Albrecht Neesse2. 1. Gastroenterology and Gastrointestinal Oncology, University Medical Center Goettingen, Goettingen, Germany. 2. Gastroenterology and Gastrointestinal Oncology, University Medical Center Goettingen, Goettingen, Germany, albrecht.neesse@med.uni-goettingen.de.
Abstract
BACKGROUND: Severe acute pancreatitis (AP) continues to be a serious gastrointestinal disease with relevant morbidity and mortality. SUMMARY: Successful clinical management requires close interdisciplinary cooperation and coordination from experienced gastroenterologists, intensive care physicians, surgeons, and radiologists. While the early phase of the disease is characterized by intensive care aspects that focus primarily on treatment of organ failure, later complications are characterized especially by (infected) necrotic collections. Here, we discuss current clinical standards and developments for conservative and interventional management of patients with severe AP. Key messages: Early targeted fluid therapy within the first 48 h is critical to improve the outcome of severe AP. Thoracic epidural analgesia may have prognostically beneficial effects due to suspected anti-inflammatory effects and increased perfusion of splanchnic vessels. Enteral feeding should be started early during severe AP. Persistent organ failure (>48 h) is the strongest predictor of poor prognosis, and local complications such as infected walled-off necrosis should be primarily treated by minimally invasive endoscopic step-up approaches that are usually superior to surgical therapy options.
BACKGROUND: Severe acute pancreatitis (AP) continues to be a serious gastrointestinal disease with relevant morbidity and mortality. SUMMARY: Successful clinical management requires close interdisciplinary cooperation and coordination from experienced gastroenterologists, intensive care physicians, surgeons, and radiologists. While the early phase of the disease is characterized by intensive care aspects that focus primarily on treatment of organ failure, later complications are characterized especially by (infected) necrotic collections. Here, we discuss current clinical standards and developments for conservative and interventional management of patients with severe AP. Key messages: Early targeted fluid therapy within the first 48 h is critical to improve the outcome of severe AP. Thoracic epidural analgesia may have prognostically beneficial effects due to suspected anti-inflammatory effects and increased perfusion of splanchnic vessels. Enteral feeding should be started early during severe AP. Persistent organ failure (>48 h) is the strongest predictor of poor prognosis, and local complications such as infected walled-off necrosis should be primarily treated by minimally invasive endoscopic step-up approaches that are usually superior to surgical therapy options.
Authors: Nicolien J Schepers; Olaf J Bakker; Marc G Besselink; Usama Ahmed Ali; Thomas L Bollen; Hein G Gooszen; Hjalmar C van Santvoort; Marco J Bruno Journal: Gut Date: 2018-06-27 Impact factor: 23.059
Authors: Hjalmar C van Santvoort; Marc G Besselink; Annemarie C de Vries; Marja A Boermeester; Kathelijn Fischer; Thomas L Bollen; Geert A Cirkel; Alexander F Schaapherder; Vincent B Nieuwenhuijs; Harry van Goor; Cees H Dejong; Casper H van Eijck; Ben J Witteman; Bas L Weusten; Cees J van Laarhoven; Peter J Wahab; Adriaan C Tan; Matthijs P Schwartz; Erwin van der Harst; Miguel A Cuesta; Peter D Siersema; Hein G Gooszen; Karel J van Erpecum Journal: Ann Surg Date: 2009-07 Impact factor: 12.969
Authors: Ji Young Bang; Juan Pablo Arnoletti; Bronte A Holt; Bryce Sutton; Muhammad K Hasan; Udayakumar Navaneethan; Nicholas Feranec; C Mel Wilcox; Benjamin Tharian; Robert H Hawes; Shyam Varadarajulu Journal: Gastroenterology Date: 2018-11-16 Impact factor: 22.682
Authors: Wolfgang Huber; Andreas Umgelter; Wolfgang Reindl; Michael Franzen; Christian Schmidt; Stefan von Delius; Fabian Geisler; Florian Eckel; Ralph Fritsch; Jens Siveke; Benedikt Henschel; Roland M Schmid Journal: Crit Care Med Date: 2008-08 Impact factor: 7.598
Authors: Peter A Banks; Thomas L Bollen; Christos Dervenis; Hein G Gooszen; Colin D Johnson; Michael G Sarr; Gregory G Tsiotos; Santhi Swaroop Vege Journal: Gut Date: 2012-10-25 Impact factor: 23.059
Authors: Sandra van Brunschot; Janneke van Grinsven; Hjalmar C van Santvoort; Olaf J Bakker; Marc G Besselink; Marja A Boermeester; Thomas L Bollen; Koop Bosscha; Stefan A Bouwense; Marco J Bruno; Vincent C Cappendijk; Esther C Consten; Cornelis H Dejong; Casper H van Eijck; Willemien G Erkelens; Harry van Goor; Wilhelmina M U van Grevenstein; Jan-Willem Haveman; Sijbrand H Hofker; Jeroen M Jansen; Johan S Laméris; Krijn P van Lienden; Maarten A Meijssen; Chris J Mulder; Vincent B Nieuwenhuijs; Jan-Werner Poley; Rutger Quispel; Rogier J de Ridder; Tessa E Römkens; Joris J Scheepers; Nicolien J Schepers; Matthijs P Schwartz; Tom Seerden; B W Marcel Spanier; Jan Willem A Straathof; Marin Strijker; Robin Timmer; Niels G Venneman; Frank P Vleggaar; Rogier P Voermans; Ben J Witteman; Hein G Gooszen; Marcel G Dijkgraaf; Paul Fockens Journal: Lancet Date: 2017-11-03 Impact factor: 79.321
Authors: Ji Young Bang; Udayakumar Navaneethan; Muhammad K Hasan; Bryce Sutton; Robert Hawes; Shyam Varadarajulu Journal: Gut Date: 2018-06-01 Impact factor: 23.059
Authors: Mihai Faur; Sorin Radu Fleaca; Claudia Diana Gherman; Ciprian Ionut Bacila; Denisa Tanasescu; Dragos Serban; Laura Carina Tribus; Corneliu Tudor; Gabriel Catalin Smarandache; Daniel Ovidiu Costea; Mihail Silviu Tudosie; Dan Sabau; Gabriel Andrei Gangura; Ciprian Tanasescu Journal: Med Sci Monit Date: 2022-07-07